As Vice President of Commercial Sales at Asimov, Imroz’s team drives partnerships to advance its genetic design platform and AI capabilities. With over 25 years in biotech, he has evolved from process development scientist to commercial leader, bridging technical innovation with scalable solutions. His expertise spans bioprocess development and platform integration, with deep knowledge of biomanufacturing workflows from gene to drug product. He leverages his technical foundation to accelerate the adoption of next-generation bioprocessing technologies.